Painful versus Insensate Diabetic Neuropathy

疼痛性糖尿病神经病与无知觉性糖尿病神经病

• 批准号: 7924551
• 负责人: Douglas E Wright
• 金额: $ 32.48万
• 依托单位: UNIVERSITY OF KANSAS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-01-01 至 2014-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7924551
• 关键词: A/J Mouse; Accounting; Address; Affect; Antioxidants; Axon; Behavioral; Development; Diabetes Mellitus; Diabetic Neuropathies; Diabetic mouse; Epidermis; Etiology; Fiber; Genes; Genetic; Goals; Green Fluorescent Proteins; Human; Hyperinsulinism; Imagery; Insulin; Insulin Receptor; Insulin Resistance; Lead; Measures; Mechanics; Mediator of activation protein; Modeling; Modification; Mus; Neurons; Neuropathy; Neurotrophin 3; Nociception; Outcome; Oxidative Stress; Pain; Pathogenesis; Patients; Peripheral; Peroxonitrite; Play; Relative (related person); Role; Sensory; Severities; Streptozocin; Symptoms; Testing; Transgenic Mice; Variant; axonal degeneration; catalyst; db/db mouse; diabetic patient; experience; human IRS2 protein; in vivo; mouse model; neurotrophic factor; new therapeutic target; prevent; promoter; public health relevance; receptor expression; relating to nervous system; research study; response; tool; type I and type II diabetes

DESCRIPTION (provided by applicant): The mechanisms that lead to painful or insensate symptoms in diabetic neuropathy (DN) are poorly understood. Many variables likely play a role in the development of these diverse symptoms, including reduced neurotrophic supply, abnormal insulin support, and oxidative stress. These symptoms may also underlie peripheral axon damage amongst select sensory neuronal subpopulations. Our long-term goal is to understand the etiology of painful and/or insensate complications of DN in relation to insulin support, oxidative stress, and peripheral axon degeneration. The central hypothesis of this proposal is that unique genetic differences underlie the differential progression and severity of diabetic neuropathy. Exploring these genetic differences will help identify mechanisms involved in the pathogenesis of diabetic neuropathy. Aim 1 will characterize the progression of painful and insensate neuropathy in type 1 (STZ- A/J vs. STZ-C57Bl/6) and type 2 (ob/ob vs. db/db) mouse models of diabetes and test whether neurotrophins can alleviate the diabetes-induced abnormalities in mechanical sensitivity. Aim 2 will test whether insulin support plays a critical role in the progression of painful or insensate neuropathy amongst these variant mouse models of diabetes. Aim 3 will examine the role of oxidative stress in the development of painful or insensate neuropathy in these diabetic mice. Aim 4 will determine whether differential damage to epidermal axons is important factor in developing painful or insensate diabetic neuropathy. Collectively, these studies will identify three possible mechanisms responsible for the variable progression of symptoms experienced within human patients and identify new therapeutic targets aimed at the severity of symptoms amongst diabetic patients. PUBLIC HEALTH RELEVANCE: This proposal will elucidate mechanisms related to the development of painful versus nonpainful symptoms in mouse models of diabetic neuropathy. The role of neurotrophins, insulin support, oxidative stress, and axonal degeneration will be investigated to identify mechanisms that lead to the neural complications associated with diabetes.

描述（由申请人提供）：导致糖尿病神经病变（DN）疼痛或感觉迟钝症状的机制尚不清楚。许多变量可能在这些不同症状的发展中发挥作用，包括神经营养素供应减少，胰岛素支持异常和氧化应激。这些症状也可能是选择的感觉神经元亚群中外周轴突损伤的基础。我们的长期目标是了解糖尿病肾病疼痛和/或感觉迟钝并发症与胰岛素支持、氧化应激和外周轴突变性的病因。该建议的中心假设是，独特的遗传差异是糖尿病神经病变的不同进展和严重程度的基础。探索这些遗传差异将有助于确定参与糖尿病神经病变发病机制。目的1将表征1型（STZ-A/J对STZ-C57 B1/6）和2型（ob/ob对db/db）糖尿病小鼠模型中疼痛性和感觉迟钝性神经病变的进展，并测试神经营养因子是否可以减轻糖尿病诱导的机械敏感性异常。目的2将测试胰岛素支持是否在这些糖尿病变异小鼠模型中疼痛或无感觉神经病变的进展中起关键作用。目的3将研究氧化应激在这些糖尿病小鼠疼痛或无感觉神经病变的发展中的作用。目的4将确定表皮轴突的不同损伤是否是发展疼痛性或无感觉性糖尿病神经病变的重要因素。总的来说，这些研究将确定三种可能的机制，负责人类患者中经历的症状的可变进展，并确定针对糖尿病患者症状严重程度的新治疗靶点。 公共卫生关系： 该建议将阐明与糖尿病神经病变小鼠模型中疼痛与非疼痛症状发展相关的机制。神经营养因子、胰岛素支持、氧化应激和轴突变性的作用将被研究，以确定导致糖尿病相关神经并发症的机制。